
Healthcare · BSE
Established in 2020, Shanmuga Hospital Limited is a NABH and NABL-accredited multispecialty hospital in Salem, Tamil Nadu, offering preventive, treatment, and rehabilitation services with advanced medical technology and 151 beds. Located on Saradha College Road, the hospital covers 45,311 sq. ft. across two blocks and three floors, providing both inpatient and outpatient care. It also operates Shanmuga Pharmacy & Diagnostics for medicines and pathology services, and Shanmuga Clinics for specialized consultations and patient transfers. The hospital’s key specialties include oncology, general surgery, orthopaedics, cardiology, paediatrics, neurology, endocrinology, and respiratory medicine. As of August 2024, it employed 72 doctors, including resident, consulting, and visiting specialists.
Price Band
₹54
Issue Size
₹20.62 Cr
Lot Size
2000 shares
GMP
+5.6%
Est. Listing
₹57
at current GMP
Subscribed
2.56x
overall
Open
13 Feb 2025
Close
17 Feb 2025
Allotment
18 Feb 2025
Refund
19 Feb 2025
Demat Credit
20 Feb 2025
Listing
21 Feb 2025
Overall Subscription
2.56x
Total Demand
QIB Multiplier
0.00x
Institutions & Funds
NII / HNI
0.71x
High Net-Worth
Retail (RII)
4.41x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| NIB | 1,812,000 | 1,286,000 | 0.71x |
| RETAIL | 1,814,000 | 7,994,000 | 4.41x |
| Total | 3,626,000 | 9,280,000 | 2.56x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 668 | 2,946 | 4.41x |
| HNIs (10L +) | 4 | 3 | 0.71x |
| HNIs (2-10L) | 20 | 14 | 0.71x |
| Total Applications | 692 | 2,963 | 4.28x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Shanmuga Hospital Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹20.62 Crores. The shares are offered at a price band of ₹54 to ₹54 per equity share on BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 2000 shares (approx. ₹1,08,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Integrated Registry Management Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-02-20, while un-allotted funds or UPI block mandates will be released on 2025-02-19.
The latest Grey Market Premium (GMP) for Shanmuga Hospital Limited IPO is ₹3 per equity share. Based on the upper price band of ₹54 to ₹54 per equity share, the estimated listing price is ₹57 (+5.6% expected listing gain).
With a lot size of 2000 shares and current GMP of ₹3, the expected profit per application lot is approx ₹6,000 (+5.6% gain). Minimum application cost is approx ₹1,08,000.
The Shanmuga Hospital Limited IPO aggregate issue size is ₹20.62 Crores with an equity price band set at ₹54 to ₹54 per equity share. The retail lot size is 2000 shares requiring a minimum capital outlay of approx. ₹1,08,000.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 2.56x (Retail: 4.41x, QIB: 0.00x, NII: 0.71x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Integrated Registry Management Services Private Limited) and the BSE status verification website on or around 2025-02-18. Investors can verify status using PAN card or application number.
Shanmuga Hospital Limited shares are scheduled to list on BSE on 2025-02-21.